Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Gastroenterology
Study Phase : Approved FDF
Sponsor : Postbiotics
Deal Size : Undisclosed
Deal Type : Agreement
Sabinsa And Postbiotics Ink Deal for PoZibio Dietary Supplement
Details : The distribution agreement aims for the dietary supplement and functional food ingredient PoZibio for age-related digestive health conditions including Leaky Gut Syndrome (LGS).
Product Name : PoZibio
Product Type : Probiotic
Upfront Cash : Undisclosed
October 23, 2024
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Gastroenterology
Highest Development Status : Approved FDF
Sponsor : Postbiotics
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
May 22, 2023
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Effects of Vigiis 101-LAB on a Healthy Populations' Gut Microflora
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
September 12, 2019
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : National Taiwan University Hospital | Chung Shan Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
August 06, 2019
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : National Taiwan University Hospital | Chung Shan Medical University
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Dental and Oral Health
Study Phase : Undisclosed
Sponsor : University of Copenhagen
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of 12 Months Supplementation With a Symbiotic Lozenge on Caries Increment in Healthy Children
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
April 26, 2019
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Dental and Oral Health
Highest Development Status : Undisclosed
Sponsor : University of Copenhagen
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Neurology
Study Phase : Undisclosed
Sponsor : International Flavors and Fragrances
Deal Size : Inapplicable
Deal Type : Inapplicable
The Cognitive Effects of 6 Weeks Administration With a Probiotic
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
July 26, 2018
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Neurology
Highest Development Status : Undisclosed
Sponsor : International Flavors and Fragrances
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Gastroenterology
Study Phase : Phase III
Sponsor : Department of Gastroenterology, Govt. Medical College, Kozhikode, Kerala, India
Deal Size : Inapplicable
Deal Type : Inapplicable
Study to Determine Efficacy of Probiotics in Irritable Bowel Syndrome
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
September 10, 2015
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Gastroenterology
Highest Development Status : Phase III
Sponsor : Department of Gastroenterology, Govt. Medical College, Kozhikode, Kerala, India
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Study Phase : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Probiotic Administration and Perennial Allergic Rhinitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
January 30, 2013
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Otolaryngology (Ear, Nose, Throat)
Highest Development Status : Undisclosed
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Study Phase : Phase II
Sponsor : VSL Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
VSL#3 and Spontaneous Bacterial Peritonitis
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
October 05, 2012
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Hepatology (Liver, Pancreatic, Gall Bladder)
Highest Development Status : Phase II
Sponsor : VSL Pharmaceuticals
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Neurology
Study Phase : Phase II/ Phase III
Sponsor : Post Graduate Institute of Medical Education and Research, Chandigarh
Deal Size : Inapplicable
Deal Type : Inapplicable
Secondary Prophylaxis of Hepatic Encephalopathy With a Probiotic Preparation
Details : Undisclosed
Product Name : Undisclosed
Product Type : Probiotic
Upfront Cash : Inapplicable
April 26, 2010
Lead Product(s) : Lactobacillus Paracasei
Therapeutic Area : Neurology
Highest Development Status : Phase II/ Phase III
Sponsor : Post Graduate Institute of Medical Education and Research, Chandigarh
Deal Size : Inapplicable
Deal Type : Inapplicable